Posts Tagged ‘Ovarian cancer’

The fight against breast cancer

The fight against breast cancer, the second most common in the world after lung and first in women, continues to progress but with some setbacks, according to research presented last weekend at the most important congress on the evil that takes place in Chicago.

The most interesting progress was reported in advanced forms of breast cancer, against which the patients are not treated with another option when standard therapy is exhausted.

A derivative of a sea sponge can prolong the life of these patients.

This synthetic component, called Eribulin masylate, mimics what is found naturally in the sponge and prevents cell division.

This international clinical trial, called Embras, first compare the effects of Eribulin with classical treatments to combat a localized breast cancer, but who has suffered recurrent or metastatic carcinoma.
Clinical Trial

The 762 participants in the trial had undergone four chemotherapies.

“These results are promising because until now there was no treatment for the sick type of advanced breast cancer or those in which they had already failed the known therapies,” said Dr. Christopher Twelves, lead author and professor of clinical pharmacology cancer at the University of Leeds in Britain.

Twelves presented this work on Sunday, during the 46th annual conference Estadunidensede Clinical Cancer Society, meeting in Chicago. Read the rest of this entry »

The various aspects related to ovarian cancer

In any type of cancer early diagnosis is critical to the success of treatment.

It will depend on the results obtained, especially in cases of malignant tumors. Ovarian cancer, one of the worst prognosis, evolve in a certain way depending on the stage where it is detected.
Dr. Jose Angel Arranz, head of the unit of urological and gynecological tumors and section chief of oncology at Hospital Gregorio Marañón in Madrid, we expose in detail the various aspects related to ovarian cancer. Risk factors for developing ovarian cancer different factors are known to influence the development of ovarian cancer.

The genetic factor may be key. Some genetic disorders can cause mutation and make us more willing to suffer this type of tumor. It is therefore very important to know the family history and make a very close medical supervision. Anyway, this risk only occurs in 10% of cases. Elsewhere, the occurrence of ovarian cancer is accidental and has no factor directly related, although the use of contraceptives ovarian or obesity can exert a minimal influence. Can we prevent ovarian cancer? The truth is that there is a specific way to prevent ovarian cancer. Thus it is necessary to sensitize the female population from age 40, or the onset of menopause, undergo vaginal controls the periodicity recommended by the gynecologist. This is the way to detect abnormal cells and reach the most time possible to treat the tumor. Read the rest of this entry »

Ovarian cancer can not be detected on physical examination

Although ovarian cancer is highly curable if diagnosed early, 75% of cases worldwide are detected in advanced stages.

This is because ovarian cancer is difficult to diagnose and often goes unnoticed for most physicians who are not oncologists.

Ovarian cancer can not be detected on physical examination during routine gynecologic consultation, as it grows up into the abdominal cavity. On the other hand, does not cause pain or other symptoms prior to suspect the disease when the tumor is small, there is no tumor marker for diagnosis.

Currently there are techniques such as CT image diagnosis, MRI, or PET, with which early diagnosis could be made, but very expensive.

However, countries like Britain, are conducting studies that seek to detect early ovarian cancer by ultrasound and tumor markers in blood are analyzed. Read the rest of this entry »

Ovarian cancer: hormone replacement therapy increases risk

Ovarian cancer: hormone replacement therapy increases risk

According to a study published in the weekly Journal of the American Medical Association, women who use hormone replacement therapy (HRT) increase vulnerability for exposure to breast cancer but are also increase the possibility of becoming a victim of cancer ovaries. And even if the treatment is less than a term of four years.

HRT previously associated with an increased risk of breast cancer

In 2002 a major study devoted to the health of women was prematurely halted when researchers found that HRT increased the risk of exposure of patients with breast cancer. The increased risk was in effect that such experiences were no longer morally acceptable. Therefore, HRT has fallen out of favor in the fight against the symptoms of menopause, and a relationship of cause and effect, the number of cancers has also decreased in corresponding proportions. Read the rest of this entry »